2-Difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice

Cancer Research

Volumn 61, Issue 20, 2001, Pages 7449-7455

  Green, Jeffrey E ^a   Shibata, Masa Aki ^a   Shibata, Eiko ^a   Moon, Richard C ^b   Anver, Miriam R ^c   Kelloff, Gary ^a   Lubet, Ronald ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ALPHA TOCOPHEROL; ANDROGEN; EFLORNITHINE; ORNITHINE DECARBOXYLASE; PRASTERONE; SELENOMETHIONINE; VIRUS LARGE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL NEOPLASM; FEMALE; GENE CONTROL; GENE EXPRESSION SYSTEM; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT; REGULATORY MECHANISM; SIMIAN VIRUS 40; TRANSGENIC MOUSE;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CELL DIVISION; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EFLORNITHINE; ESTRADIOL; FEMALE; GENE EXPRESSION; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PRECANCEROUS CONDITIONS; PROSTATIC NEOPLASMS; RATS; TRANSGENES;

EID: 0035886864     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mammary gland neoplasia in long term rodent studies
2. Deregulated expression of cyclin D1 and other cell cycle related genes in carcinogen induced rat mammary tumors
3. Evaluation of the antitumor activity of the non-steroidal anti-estrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model
4. Anti-tumor actions of keoxifene and tamoxifen in the MNU-induced rat mammary tumor cancer model
5. Chemopreventive effects of the aromatase inhibitor vorozole (R83842) in the MNU-induced mammary cancer model
6. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene
7. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein
8. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus
9. Tumor suppressor genes and their roles in breast cancer
10. Molecular biology of prostate cancer
11. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: Ductal epithelial cell targeting with multistage progression to carcinoma
12. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: Suppression of apoptosis during the transition from preneoplasia to carcinoma
13. Estrogen promotes increased mammary tumor development in C3(1)/SV40 Tag transgenic mice: Paradoxical loss of ERα expression during tumor development
14. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: Reduction in protective apoptotic response at the preneoplastic stage
15. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice
16. 9-cis-retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice
17. Modulation of MNU-induced breast cancer in Sprague Dawley rats by dehydroepiandrosterone: Dose dependent inhibition, effects of limited exposure, effects on peroxisomal enzymes, and lack of effects on levels of Ha-Ras mutations
18. Decarboxylation of α-difluoromethylornithine by ornithine decarboxylase
19. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: Reduced incidence of 1, 2-dimethylhydrazine-induced colon tumors in mice
20. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a NSAID with difluoromethylornithine, an ornithine decarboxylase inhibitor in diet
21. Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin
22. Effect of concentration of D, L-2-difluoromethylornithine on mammary carcinogenesis
23. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid
24. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized-controlled trial
25. Prostate cancer and supplementation with vitamin E and β-carotene: Incidence and mortality in a controlled trial
26. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: Histopathological and molecular biological alterations
27. The mammary pathology of genetically engineered mice: The consensus report and recommendations from the Annapolis Meeting
28. The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts
29. Haploid loss of Ki-ras delays mammary tumor progression in C3(1)/SV40 Tag transgenic mice
30. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone
31. Effect of dehydroepiandrosterone and the anti-estrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts
32. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV 16 transgenic mice
33. Difluoromethylornithine is effective both as a preventive and therapeutic agent against the development of UV skin carcinogenesis in SKH hairless mice
34. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat
35. Reducing the risk of breast cancer